Immune Response and Exhaled Breath Profile Changes after Initiation of CFTR Modulator Therapy in Chi...
Immune Response and Exhaled Breath Profile Changes after Initiation of CFTR Modulator Therapy in Children with CF
About this item
Full title
Author / Creator
Publisher
Jackson: MDPI AG
Journal title
Language
English
Formats
Publication information
Publisher
Jackson: MDPI AG
Subjects
More information
Scope and Contents
Contents
Background: In recent years, cystic fibrosis transmembrane regulator (CFTR) modulating therapy has made it possible to treat the underlying pathophysiological defect in children with cystic fibrosis (CF). Response to therapy varies among patients. We investigated the immune responses and exhaled breath profile changes after the initiation of CFTR m...
Alternative Titles
Full title
Immune Response and Exhaled Breath Profile Changes after Initiation of CFTR Modulator Therapy in Children with CF
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_e34291284c6842d9a83304b076c698b2
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_e34291284c6842d9a83304b076c698b2
Other Identifiers
ISSN
2673-8937
E-ISSN
2673-8937
DOI
10.3390/ijtm4030037
